4//SEC Filing
Price Kevin 4
Accession 0001104659-09-008017
CIK 0001326190other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:07 PM ET
Size
6.0 KB
Accession
0001104659-09-008017
Insider Transaction Report
Form 4
Price Kevin
President - PharmAthene UK,Ltd
Transactions
- Award
Stock Option (right to buy)
2009-01-21+1,900→ 166,900 totalExercise: $2.46Exp: 2019-01-21→ Common Stock (1,900 underlying)
Footnotes (2)
- [F1]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On January 21, 2009, the date such stock options were granted, the closing price of the Issuer's common stock was $2.46 per share.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001440471
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:07 PM ET
- Size
- 6.0 KB